China Feihe Ltd
HKEX:6186
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.43
6.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one China Feihe Ltd stock under the Base Case scenario is 5.02 HKD. Compared to the current market price of 5.71 HKD, China Feihe Ltd is Overvalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
China Feihe Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for China Feihe Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
China Feihe Ltd. is a leading infant formula and nutrition products company that has made a significant mark in the rapidly growing Chinese dairy sector. Founded in 1962, this Beijing-based firm has transformed itself into a powerhouse in the premium baby formula market, capitalizing on the increasing demand for high-quality nutrition products among Chinese parents. With key investments in research and development, along with a commitment to high standards in production, Feihe has cultivated a strong brand identity, synonymous with trust and premium quality. The company's careful sourcing of milk from Canadian farms, known for their clean and safe dairy practices, further bolsters its reputa...
China Feihe Ltd. is a leading infant formula and nutrition products company that has made a significant mark in the rapidly growing Chinese dairy sector. Founded in 1962, this Beijing-based firm has transformed itself into a powerhouse in the premium baby formula market, capitalizing on the increasing demand for high-quality nutrition products among Chinese parents. With key investments in research and development, along with a commitment to high standards in production, Feihe has cultivated a strong brand identity, synonymous with trust and premium quality. The company's careful sourcing of milk from Canadian farms, known for their clean and safe dairy practices, further bolsters its reputation and ensures that it meets the stringent expectations of health-conscious consumers.
For potential investors, Feihe represents a unique opportunity to tap into the booming baby formula market in China, which is projected to maintain its growth trajectory driven by rising disposable incomes and a shift toward premium products. The company's focus on innovation and its expansion into international markets position it well within the competitive landscape. With strategic alliances and robust marketing initiatives, Feihe has demonstrated a solid ability to adapt to changing market conditions, making it a compelling prospect for investors looking for exposure in the Chinese consumer sector. As the global demand for high-quality nutrition continues to rise, Feihe's established presence and growth potential contrast favorably against industry peers, presenting a narrative of resilience and promise in a vital market.
China Feihe Ltd., a company primarily focused on the dairy industry, has a few core business segments that define its operations:
-
Infant Formula Products: This is one of the largest segments of China Feihe's business. The company produces and sells a variety of infant formula products, catering to different age groups and dietary needs. This segment benefits from the growing demand for high-quality infant nutrition in China.
-
Milk Powder and Dairy Products: Besides infant formula, China Feihe also offers a range of other milk powder products and dairy items. This segment includes products for children and adults, expanding their market reach beyond just infants.
-
Nutrition and Health Supplements: Feihe has expanded into the health supplement niche, offering products that complement its dairy offerings, focusing on nutrition for different demographics, including adults and seniors.
-
E-commerce and Retail: China Feihe utilizes various online platforms and retail channels to distribute its products. This segment is crucial for reaching a broader customer base, particularly among younger, tech-savvy consumers.
-
Export Markets: The company has been increasingly targeting international markets, particularly in North America and other regions, to diversify its revenue streams and capitalize on the demand for high-quality dairy products abroad.
Overall, these segments reflect China Feihe Ltd.'s strategic focus on high-quality dairy nutrition, consumer health, and expanding its footprint both domestically and internationally.
China Feihe Ltd., a leading manufacturer of infant formula and dairy products in China, holds several unique competitive advantages over its rivals:
-
Strong Brand Recognition: Feihe has established itself as a trustworthy brand known for high-quality products. Its reputation is particularly strong in the premium infant formula segment, which appeals to health-conscious parents.
-
Local Sourcing and Production: By leveraging local milk sources, Feihe can maintain higher quality control and freshness. This is crucial in the infant formula market, where safety and quality are paramount.
-
Research and Development: Feihe invests significantly in R&D, particularly in understanding the nutritional needs of infants and developing products that meet those needs. This leads to innovative product offerings that can differentiate it from competitors.
-
Regulatory Compliance and Trust: Following past issues in China's dairy industry, Feihe has made considerable efforts to comply with strict safety regulations and to be transparent in its operations, which helps build trust with consumers.
-
Targeted Marketing Strategies: Their marketing strategies often resonate more deeply with local consumers, using culturally relevant messaging and focusing on the specific needs of Chinese families.
-
Distribution Network: A robust distribution network ensures that Feihe products are accessible across various retail channels, from e-commerce to traditional brick-and-mortar stores.
-
Focus on Premium Products: Feihe is known for its high-end infant formula products, allowing it to command higher prices and margins compared to competitors focusing more on the mass market.
-
Adaptation to Consumer Preferences: The company has shown an ability to adapt quickly to changing consumer preferences, particularly in the rise of health-focused and organic products.
-
Partnerships and Collaborations: Collaborations with research institutions and universities enhance its credibility and innovation capacity, fostering advancements in product formulation.
These competitive advantages allow China Feihe Ltd. to maintain a strong position in a highly competitive market, especially as consumer preferences continue to evolve.
China Feihe Ltd, known for its high-quality infant formula and dairy products, faces several risks and challenges that could impact its operations and growth in the near future:
-
Regulatory and Compliance Risks: The food and beverage industry in China is heavily regulated. Any changes in food safety laws, import regulations, or labeling requirements could pose significant challenges. Adhering to the strict standards set by both Chinese authorities and international bodies is crucial.
-
Market Competition: The infant formula market in China is highly competitive, with both domestic and international brands vying for market share. Intense competition may lead to price wars and increased marketing expenses, which could squeeze profit margins.
-
Supply Chain Disruptions: Global supply chain issues, exacerbated by the COVID-19 pandemic, can affect the availability and cost of raw materials. If China Feihe faces difficulties in sourcing high-quality milk and other ingredients, it could compromise product quality and availability.
-
Changing Consumer Preferences: There is a growing trend among consumers towards organic and healthier products. If China Feihe fails to align its product offerings with these changing consumer preferences, it could lose market relevance.
-
Economic Volatility: Economic downturns or fluctuations in the Chinese economy can impact consumer purchasing power, thereby affecting sales of premium products like infant formula.
-
Trade Relations and Tariffs: Ongoing tensions between China and other countries, particularly the United States, might lead to tariffs or trade barriers that could adversely affect export operations and raw material costs.
-
Brand Reputation Risks: Any incidents related to product safety, quality control, or negative publicity surrounding the brand can lead to consumer distrust, which is particularly critical in the food sector.
-
Technological Changes: As digital marketing and e-commerce become increasingly important, any lag in adopting new technologies or shifts in online consumer behavior can hinder growth and market penetration.
-
Demographic Changes: Changes in birth rates and family structures can directly affect the demand for infant formula. A declining birth rate in China could pose a long-term challenge for the company's core market.
-
Geopolitical Risks: Increasing geopolitical tensions and instability can create uncertainties in the operating environment, potentially affecting business operations and consumer sentiment.
Addressing these risks effectively requires ongoing strategic planning, investment in technology, and a focus on maintaining high product quality and strong consumer relationships.
Revenue & Expenses Breakdown
China Feihe Ltd
Balance Sheet Decomposition
China Feihe Ltd
Current Assets | 22.4B |
Cash & Short-Term Investments | 19.1B |
Receivables | 308.5m |
Other Current Assets | 3B |
Non-Current Assets | 13.2B |
Long-Term Investments | 460.6m |
PP&E | 12.2B |
Intangibles | 127.6m |
Other Non-Current Assets | 382.5m |
Current Liabilities | 6.7B |
Accounts Payable | 1.6B |
Other Current Liabilities | 5.1B |
Non-Current Liabilities | 3.3B |
Long-Term Debt | 809m |
Other Non-Current Liabilities | 2.5B |
Earnings Waterfall
China Feihe Ltd
Revenue
|
19.9B
CNY
|
Cost of Revenue
|
-6.7B
CNY
|
Gross Profit
|
13.2B
CNY
|
Operating Expenses
|
-7.4B
CNY
|
Operating Income
|
5.8B
CNY
|
Other Expenses
|
-2.2B
CNY
|
Net Income
|
3.6B
CNY
|
Free Cash Flow Analysis
China Feihe Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
China Feihe Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
China Feihe Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Feihe Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.
Score
China Feihe Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China Feihe Ltd
According to Wall Street analysts, the average 1-year price target for China Feihe Ltd is 4.91 HKD with a low forecast of 3.43 HKD and a high forecast of 7.77 HKD.
Dividends
Current shareholder yield for China Feihe Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
China Feihe Ltd. engages in the development, production and sale of infant formula milk and other dairy products. The company is headquartered in Beijing, Beijing. The company went IPO on 2019-11-13. The firm's main products include infant milk formula products, adult milk-powder, liquid milk, goat milk infant formula, and a small amount of soybean powder, among others. The firm's milk formula product series include super-premium Astrobaby, Super-premium Organic Zhenzhi and so on. The firm conducts its businesses within the domestic market and to overseas markets such as the United States.
Contact
IPO
Employees
Officers
The intrinsic value of one China Feihe Ltd stock under the Base Case scenario is 5.02 HKD.
Compared to the current market price of 5.71 HKD, China Feihe Ltd is Overvalued by 12%.